Investors purchased shares of CVS Health Corporation (NYSE:CVS) on weakness during trading on Friday. $77.55 million flowed into the stock on the tick-up and $44.94 million flowed out of the stock on the tick-down, for a money net flow of $32.61 million into the stock. Of all stocks tracked, CVS Health Corporation had the 20th highest net in-flow for the day. CVS Health Corporation traded down ($0.03) for the day and closed at $93.37

A number of research analysts recently issued reports on the stock. Citigroup Inc. lifted their price target on shares of CVS Health Corporation from $105.00 to $115.00 and gave the company a “neutral” rating in a research report on Monday, May 9th. Jefferies Group lifted their price target on shares of CVS Health Corporation from $110.00 to $122.00 and gave the company a “buy” rating in a research report on Thursday, May 12th. FBR & Co reissued a “buy” rating on shares of CVS Health Corporation in a research report on Saturday, May 14th. Deutsche Bank AG lifted their price target on shares of CVS Health Corporation from $99.00 to $108.00 and gave the company a “hold” rating in a research report on Wednesday, August 3rd. Finally, Zacks Investment Research raised shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 3rd. Six equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $113.02.

The company has a 50-day moving average of $95.90 and a 200-day moving average of $98.51. The company has a market cap of $100.05 billion and a PE ratio of 21.59.

CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.02. The business earned $43.70 billion during the quarter, compared to analyst estimates of $44.28 billion. CVS Health Corporation’s quarterly revenue was up 17.6% compared to the same quarter last year. During the same quarter last year, the company posted $1.19 EPS. On average, analysts expect that CVS Health Corporation will post $5.86 EPS for the current fiscal year.

Other institutional investors have modified their holdings of the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of CVS Health Corporation by 1.0% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 72,347 shares of the pharmacy operator’s stock valued at $7,073,000 after buying an additional 741 shares during the period. Advantus Capital Management Inc boosted its stake in shares of CVS Health Corporation by 1.8% in the fourth quarter. Advantus Capital Management Inc now owns 106,662 shares of the pharmacy operator’s stock worth $10,428,000 after buying an additional 1,899 shares during the last quarter. Twin Capital Management Inc. boosted its stake in shares of CVS Health Corporation by 8.8% in the fourth quarter. Twin Capital Management Inc. now owns 95,854 shares of the pharmacy operator’s stock worth $9,372,000 after buying an additional 7,760 shares during the last quarter. Century Capital Management LLC boosted its stake in shares of CVS Health Corporation by 44.8% in the fourth quarter. Century Capital Management LLC now owns 47,504 shares of the pharmacy operator’s stock worth $4,644,000 after buying an additional 14,708 shares during the last quarter. Finally, Bank of Montreal Can boosted its stake in shares of CVS Health Corporation by 0.4% in the fourth quarter. Bank of Montreal Can now owns 4,967,220 shares of the pharmacy operator’s stock worth $485,648,000 after buying an additional 19,949 shares during the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.